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Abstract
Segregation of mutant mtDNA in human tissues and through the germline is debated, with no consensus about the nature
and size of the bottleneck hypothesized to explain rapid generational shifts in mutant loads. We investigated two maternal
lineages with an apparently different inheritance pattern of the same pathogenic mtDNA 3243A.G/tRNALeu(UUR) (MELAS)
mutation. We collected blood cells, muscle biopsies, urinary epithelium and hair follicles from 20 individuals, as well as
oocytes and an ovarian biopsy from one female mutation carrier, all belonging to the two maternal lineages to assess
mutant mtDNA load, and calculated the theoretical germline bottleneck size (number of segregating units). We also
evaluated ‘‘mother-to-offspring’’ segregations from the literature, for which heteroplasmy assessment was available in at
least three siblings besides the proband. Our results showed that mutation load was prevalent in skeletal muscle and
urinary epithelium, whereas in blood cells there was an inverse correlation with age, as previously reported. The
histoenzymatic staining of the ovarian biopsy failed to show any cytochrome-c-oxidase defective oocyte. Analysis of four
oocytes and one offspring from the same unaffected mother of the first family showed intermediate heteroplasmic mutant
loads (10% to 75%), whereas very skewed loads of mutant mtDNA (0% or 81%) were detected in five offspring of another
unaffected mother from the second family. Bottleneck size was 89 segregating units for the first mother and 84 for the
second. This was remarkably close to 88, the number of ‘‘segregating units’’ in the ‘‘mother-to-offspring’’ segregations
retrieved from literature. In conclusion, a wide range of mutant loads may be found in offspring tissues and oocytes,
resulting from a similar theoretical bottleneck size.
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Introduction
Human mitochondrial DNA (mtDNA) is assumed to be a clonal
multi-copy genome of 16,5 kb that is strictly maternally inherited.
In each cell, mtDNA may be present either as identical copies
(homoplasmy) or as a mixed population of two or more different
sequences (heteroplasmy or polyplasmy) [1]. Heteroplasmic
mtDNA nucleotide changes, including those causing mitochon-
drial encephalomyopathies [2], segregate in tissues of the
developing embryo as well as in germline cells. Somatic
segregation of pathogenic mutations is relevant for clinical
expression of mitochondrial diseases by affecting energy-depen-
dent tissues that accumulate high, supra-threshold mutant loads
[2,3]. Germline segregation is crucial for maternal transmission of
variable mutant loads to the offspring [3].
Heteroplasmy may be theoretically due to coexistence of
individual organelles containing either exclusively mutant or
exclusively wild-type genomes (inter-mitochondrial heteroplasmy)
or to the coexistence in each mitochondrion of both mutant and
wild-type genomes in different proportions (intra-mitochondrial
heteroplasmy) [4]. The mtDNA molecules are associated with
specific coating proteins in discrete nucleoids, physically attached
to the inner mitochondrial membrane [5], which may themselves
be either homoplasmic or heteroplasmic [6]. Admixture and
complementation of heteroplasmic mtDNA genomes may be
accomplished by mitochondrial fusion events and exchange of
mtDNA between nucleoids [7]. Variable efficiency in comple-
mentation has been observed in cellular models harboring
different mtDNA mutations [8,9] but inter-mitochondrial com-
plementation has been documented in a mito-mouse model
carrying an mtDNA deletion [10]. Recent evidence suggests that
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nucleoids do not exchange genetic material frequently and are
probably homoplasmic [11,12], and may contain up to only one
mtDNA molecule [13].
The load of mutant mtDNA may vary markedly between a
mother and each of her children and a bottleneck mechanism has
been postulated during the germline segregation of mutant
mtDNA to explain rapid shifts of heteroplasmy observed within
one generation [14–16]. However, the nature of the bottleneck
mechanism in humans is still under intense debate. Recent studies
led to several potential mechanisms that are not necessarily
mutually exclusive. These include i) a marked reduction in the
number of mtDNA molecules during the early stages of germline
development [17]; ii) aggregation of identical segregating units
without a reduction of mtDNA copy number, leading to rapid
segregation due to sampling effect [18,19]; iii) preferential
replication of a subpopulation of genomes, implying an active
selection [20]; iv) rapid mtDNA segregation in preimplantation
embryos [21]. Most of the data collected so far have been obtained
by studying animal models segregating clusters of mtDNA
polymorphic variants [22]. The experimental models provided
by animals carrying pathogenic mtDNA mutations (‘‘mutator’’
mouse) suggested a purifying selection for the most severe mtDNA
mutations [23,24]. In humans, the bottleneck model has been
tested only in a few studies, using both neutral polymorphisms and
pathogenic mtDNA mutations segregating in relatively small
pedigrees [25–30]. Apparently, different segregation patterns may
operate depending on the mtDNA pathogenic mutation: the
8993T.G mutation associated with neuropathy, ataxia, retinitis
pigmentosa (NARP) was characterized by skewed segregation in
offspring or oocytes [27], whereas the 3243A.G/tRNALeu(UUR)
mutation associated with mitochondrial encephalomyopathy,
lactic acidosis, stroke-like episodes (MELAS) followed a random
genetic drift model of segregation in a large sample of oocytes from
a single woman [30].
We combined quantitative analysis of mtDNA heteroplasmy in
both oocytes and somatic tissues to study the germline and somatic
segregation of the 3243A.G/tRNALeu(UUR) pathogenic mutation
[31] in two Italian pedigrees.
Materials and Methods
Patients
We studied two previously reported [32] Italian maternal
lineages (Family A in Figure 1 and Family B in Figure 2) carrying
the heteroplasmic 3243A.G/tRNALeu(UUR) mutation. Briefly, the
proband from Family A (II-2, Figure 1) was affected with chronic
progressive external ophthalmoplegia (CPEO), whereas the
proband from Family B (II-4, Figure 2) had the typical MELAS
syndrome. Both probands had ragged-red-fibers (RRF) and/or
cytochrome c oxidase (COX)-negative fibers in skeletal muscle
with different mutation loads.
In family A, the proband’s only daughter (III-2) was asymp-
tomatic excepted for frequent migraine attacks and she lacked
RRF in muscle biopsy. Her son (IV-1) has been treated with
growth hormone for short stature.
In family B, the proband’s mother (I-2) was clinically
asymptomatic, whereas the proband’s only son (III-3) recently
developed the full-blown MELAS syndrome.
After approval by the internal review board (1996–1998,
Institute of Neurological Clinic, University of Bologna, Director
Prof. Elio Lugaresi) and signed informed consent, 20 maternally
related individuals from both families agreed to be enrolled in the
study aimed at assessing the MELAS mutation loads in somatic
tissues. In most cases, we have been able to collect blood samples
(leukocytes- and platelet-enriched pellets or whole blood), muscle
biopsies, urinary epithelium, and hair follicles. The proband’s only
daughter in Family A (III-2), also underwent ovarian stimulation
to allow collection of oocytes for genetic analysis and gave
informed consent for an ovarian biopsy at the time of oocytes
collection. Moreover, two of the proband’s sisters in Family B (II-5
and II-7) became pregnant during the time of our investigation
and consented to prenatal diagnosis on cells recovered from
amniotic fluid.
mtDNA Analysis
Total DNA has been extracted by standard phenol/chloro-
phorm methods from somatic tissues, including amniocytes. Total
oocyte DNA was recovered from single oocytes. Briefly, each
oocyte was placed in an Eppendorf tube with one drop PBS and
1.5 mL proteinase K 10 mg/ml in ice, and centrifuged 30 sec
3000 rpm in an Eppendorf table-top centrifuge. After adding
50 mL sterile mineral oil, the mixture was centrifuged 30 sec as
before, then digested at 37uC for one hour; digestion was blocked
by boiling at 95uC for 15 minutes, followed by 80uC for 20
minutes. Each sample was then frozen and maintained at 280uC
until the PCR amplification.
Heteroplasmy was determined by restriction fragment length
polymorphism (RFLP) analysis after hot-last cycle PCR amplifi-
cation as previously described [32]. The sensitivity of this method
allowed detection of heteroplasmy as low as 1%.
Estimation of Bottleneck Size in Our Families and Review
of Previous Reports
We assessed the bottleneck size in two germline segregations
from unaffected females carriers of the MELAS mutation to their
offspring or oocytes. For the first segregation (Family A; female III-
2 in Figure 1), we were able to estimate the proportion p of mutant
mtDNA from the heteroplasmic load found in four primary
oocytes collected from this woman and in the somatic tissues
available from her only son. For the second segregation (Family B;
female I-2 in Figure 2), the same estimate was obtained by
averaging the loads of mutant mtDNA found in somatic tissues of
five offspring. In both cases, p was taken as an estimate of p, the
true proportion in the sample population. Under the binomial
distribution, the variance was estimated by p(1–p)/n, whereas
confidence intervals for p were estimated solving for the equation
z= (p–p)/!p (1–p)/n. The binomial distribution applies if the levels
of mutant mtDNA are solely determined by a sampling error such
as may occur during a bottleneck. Confidence intervals were used,
in both pedigrees, to test whether the mutant load in a given
progeny was compatible with a random sampling event (i.e. the
bottleneck in the mother).
The number of ‘‘units’’ undergoing the bottleneck was
estimated according to equation (1) in Brown et al. [30] under
the assumption that 24 cell divisions are needed to produce the full
set of primary oocytes. Each segregating ‘‘unit’’ could be an
mtDNA molecule or a nucleoid. We also applied the same
statistical approach to a set of ‘‘mother-to-offspring’’ segregations
reported in the literature, updating the series reviewed by
Chinnery and colleagues [33], and evaluating tissue heteroplasmy
in families in which there were at least three siblings besides the
proband [34–39].
Oocytes and Ovarian Biopsy
The proband’s unaffected daughter in Family A (III-2)
underwent surgical laparoscopy during which oocytes were
retrieved from both ovaries and a biopsy was taken from the
Bottleneck Size in MELAS Mutation
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right ovary. The oocytes were obtained after ovarian stimulation
using a combination of a gonodotrophin-releasing hormone
analogue (Triptoreline, Decapeptyl 3.75; Ipsen Biotec, Paris,
France) and menotrophins (Metrodin HP, 75 IU; Serono, Milan,
Italy) and immediately frozen in liquid nitrogen for DNA analysis
[40].
The ovarian biopsy specimen was frozen in liquid nitrogen-
cooled isopentane for histological and histoenzymatic staining,
following the standard procedure used for muscle biopsies [41].
Ten mM sections were processed for hematoxylin/eosin standard
staining and cytochrome c oxidase/succinate dehydrogenase
(COX/SDH) double histoenzymatic staining. One age-matched
control ovarian biopsy was used for comparison.
Results
The heteroplasmic load of MELAS mutation assessed in various
somatic tissues of maternally related individuals from Families A
and B is summarized in Figures 1 and 2. The mutant mtDNA
segregated only in some individuals along the maternal line of both
families, as previously reported [32].
In Family A, the mutational event most likely occurred between
individual I-2 and the CPEO proband (II-2 in Figure 1),
considering that mutant mtDNA was absent in all other siblings
Figure 1. Pedigree of Family A. Filled symbol indicates the proband (II-2). Shaded symbols indicate asymptomatic individuals carrying the MELAS
mutation. Asterisk indicate all the individuals who underwent molecular investigation. Individual III-2 underwent double samplings for some tissues
(asterisk, in the table).
doi:10.1371/journal.pone.0096663.g001
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of II-2, as well as in two maternal descendants in the third
generation (individuals III-4 and III-5). We relied on the results in
mtDNA from muscle and urinary epithelium, or at least one of the
two tissues. The MELAS mutation was transmitted to the
proband’s daughter, individual III-2 and to her son (IV-1), both
currently unaffected. The mutant load slowly increased through
these three generations, as shown by all tissues tested. In all
individuals, the mutant loads in urinary epithelium and skeletal
muscle were remarkably similar, whereas in blood-derived cells
they were inversely correlated with age, as reported by others [42–
44].
Four MII oocytes were retrieved from the proband’s daughter
(III-2 in Figure 1). Under inverted microscope, the ooplasm had
normal size and perivitelline space. Ultrastructurally, the oocytes
had normally shaped nuclei with finely dispersed chromatin. The
normal morphology of follicles and stromal cells was confirmed by
ultrastructural analysis (data not shown).
On double histoenzymatic staining for cytochrome-c-oxidase
(COX) and succinate dehydrogenase (SDH) activities, oocytes
within follicles were very intensely stained, whereas granulose cells
had a less intense stain (Figure 3). This is compatible with the great
amount of mtDNA copy number and mitochondria in oocytes.
Remarkably, we failed to detect any sign of COX deficiency,
neither in the oocyte cytoplasm nor in the other cell types
(i.e.granulosa cells of the ovarian follicle and other stromal cells).
Figure 4 shows the RFLP analysis in the four oocytes from
individual III-2, which revealed mutant loads ranging from 10%
to 67%.
In Family B, the female founder (I-2 in Figure 2) showed mutant
mtDNA in skeletal muscle and urinary epithelium. This woman
segregated mutant mtDNA only in one of her offspring, the
proband affected with MELAS (II-4). None of the proband’s
siblings had mutant mtDNA in any of the tissues investigated, nor
did two maternal descendants in the third generation (III-1 and
III-2). Furthermore, amniocytes collected during pregnancies of
individuals II-5 and II-7 were also negative for the MELAS
mutation (data not shown). Mutant mtDNA was transmitted from
the proband to her only son, who is affected with MELAS like his
mother. The tissue distribution pattern of somatic mutant loads
was similar to that described for Family A, except that the female
founder of this pedigree had undetectable mutant mtDNA in
blood, only traces in urinary epithelium but a relatively high
amount in skeletal muscle. Remarkably, this woman had had two
Figure 2. Pedigree of Family B. Filled symbol indicates the proband (II-4). Individual II-4 underwent double samplings for some tissues (asterisk, in
the table).
doi:10.1371/journal.pone.0096663.g002
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miscarriages besides the five healthy offspring and the daughter
with MELAS.
To investigate the ‘‘mother-to-offspring’’ germ line segregation
of the MELAS mutation in these two maternal lineages (from
individual III-2 in Family A and from individual I-2 in Family B),
we estimated the percentage of mutant mtDNA in somatic tissues
of each offspring in Families A and B, and in each oocyte in
Family A. The germline segregation was compatible with a
bottleneck event in the mother, according to the binomial
distribution. Thus, different mutation loads in the progeny have
to be ascribed to chance alone. The bottleneck size, based on the
assumption that 24 cell divisions are needed to produce primary
oocytes, consisted of 89 segregating units for Family A and 84 for
Family B, if we consider only the mutant load in skeletal muscle
(Table 1). If we take into account the mtDNA heteroplasmy of
urinary epithelium in both Family A and B, the segregation units
were 108 (Family A, oocytes from subject III-2 plus urinary
epithelium from the only son) and 110 (Family B, urinary
epithelium from all offspring) (Table 1).
We reviewed previously reported families segregating the
MELAS mutation [33–39] and selected those in which the p of
mutant mtDNA was reported for both mother and progeny and
included, besides the proband, at least three siblings. We then
subjected these ‘‘mother-to-offspring’’ segregations retrieved from
the literature to the same test for the binomial distribution that we
have used for the analysis of our Italian families. In all included
cases (see Table I) the p of mutant mtDNA in the progeny was
compatible with a random segregation event in the mother. The
number N of ‘‘segregating units’’ was in the range of 59–120, with
an average number of N= 88 (confidence interval at the 0.95 level
was 75# N #101), remarkably close to the values estimated in our
study, N= 89 for Family A and N= 84 for Family B. These
segregations were calculated using different somatic tissues, such as
Figure 3. Ovarian follicles. A and C show two ovarian follicles (arrows) of individual III-2 (Family A), stained, respectively, with HE and COX/SDH; B
and D, similarly, show three ovarian follicles (arrows), at different stages of maturation, of a control individual (magnification 20x). No evidence of
reduced COX stain was observed in any of the tissues from the ovarian biopsy of the individual III-2, in particular the oocytes, as compared to the
control (asterisks).
doi:10.1371/journal.pone.0096663.g003
Figure 4. Quantification of the 3243A.G/tRNALeu mutation
loads in four primary oocytes from individual III-2 (Family A)
and from five control oocytes.
doi:10.1371/journal.pone.0096663.g004
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skeletal muscle, hair follicles, fibroblasts and urinary epithelium
(Table 1).
Overall, these cumulative data show a close relationship
between the tissues analyzed and the relative calculation for
bottleneck size (N): for both a postmitotic tissue, such as skeletal
muscle and oocytes, N resulted similar, despite the resulting
mutation load in offspring was largely distributed in Family A and
skewed to the extremes in Family B. Our literature revision
revealed that in most cases the ‘‘mother-to-offspring’’ transmission
resembled Family A [34,35,36,38,39], whereas only one family
was essentially identical to Family B [37], still with very similar
estimated bottleneck sizes. The overview of the relationship
between mother and offspring mutant loads from our Families A
and B, and those retrieved from literature are graphically
represented in Figure 5, including the theoretical bottleneck
calculated for each of these segregations.
Discussion
This study shows that germline segregation of the 3243A.G/
tRNALeu MELAS mutation may lead to a wide range of
mutational loads in offspring through a similar bottleneck size.
Its estimation in the two Italian families here investigated was
remarkably close to the average number of segregating units
calculated for other ‘‘mother-to-offspring’’ germline segregations
retrieved from the literature. In Family A, individual III-2
transmitted intermediate, largely distributed loads of heteroplas-
mic mutant mtDNA (10% to 75% mutant; Figure 5), as measured
in four of her oocytes and in her only son. This resembled most of
the other segregations retrieved from the literature (Figure 5). In
contrast, in Family B we observed a sharply skewed transmission of
mutant from individual I-2 to only one of her offspring (81%
mutant; Figure 5). All other siblings had only wild-type mtDNA in
the tissues analyzed (0% mutant; Figure 5), including amniocytes
from two pregnancies of individuals II-5 and II-7. This was
paralleled by only one family previously reported by Huang et al.
[37], which had an essentially identical distribution of mutant
loads in skeletal muscle of offspring (Figure 5).
The number of ‘‘segregating units’’ (bottleneck size), calculated
in these two Italian families and in the several cases retrieved from
the literature [28–30] was substantially lower than the 173
segregating units estimated by Brown et al. in the only study that
sampled a large set of oocytes (N = 82) from a female carrier of the
same MELAS mutation [30]. An important limitation of the
current study and those retrieved from the literature is the large
error associated with the variance estimated from a very low
sample number ($4) [45]. This is an obvious drawback by
working with living patients from human pedigrees. A recent study
[46] on the segregation of the MELAS mutation through the
human embryofetal development concluded that random drift
drives germline segregation, similar to Brown’s and colleagues
conclusions [30], but with some appreciable individual-dependent
differences in bottleneck size. Interestingly, in a study based on a
large cohort of individuals carrying the MELAS mutation, the
mothers with a mutation load greater that 50% tended to have
offspring with lower or equal heteroplasmy, whereas the opposite
was true for mothers with less than or equal to 50% mutation load
[47]. These authors concluded that the random genetic drift
model could not fully explain the transmission of the MELAS
mutation [47]. Ascertainment bias has also to be considered. The
recent finding that one in 200 healthy humans harbors a
pathogenic mtDNA mutation out of the ten most frequent,
indicates that there is a large pool of maternal lineages were
probably these mutations segregate silently, and are possibly
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selected out, missing to express any pathology and not being
ascertained at all [48]. Thus, investigation of single pedigrees
identified by an affected proband introduces a bias that may be
resolved by pooling large cohort of families through multi-centric
studies, or by meta-analyses of reported pedigrees.
The analysis of somatic segregation of the MELAS mutation in
our two families confirmed that the mutant load is inversely
correlated with age in blood cells, whereas skeletal muscle is the
tissue of choice, followed by urinary epithelial cells, for detection of
the mutation [42–44]. The pattern of mutational load in somatic
tissues distinguished the two families, which also differed for the
clinical phenotype. In Family A (CPEO), the mutational load in
the unaffected female individual III-2 appeared to be similar in
skeletal muscle (44%) and urinary epithelium (29%–46%), whereas
in the female individual I-2 of Family B (MELAS) the mutational
load in skeletal muscle (40%) was much higher than in urinary
epithelium (1%). This latter observation might be related to the
skewed transmission of mutant mtDNA in the offspring of this
woman, resulting in one MELAS patient (81% mutant mtDNAs in
skeletal muscle), two miscarriages conceivably due to very high
mutant loads, and all remaining unaffected individuals with wild-
type mtDNA.
Many recent studies have tried to tackle the issue of mtDNA
germline segregation testing the bottleneck hypothesis [17–22].
These studies have employed murine and primate heteroplasmic
models and there is no consensus on whether the bottleneck exists,
whether there are one or more bottlenecks, and at what stage of
development the bottleneck(s) operate. These models do not
closely recapitulate the situation of a single mtDNA pathogenic
mutation segregating along the maternal line of human pedigrees
because most heteroplasmic animals were generated by mixing
two mitochondrial genomes that differed for a cluster of
polymorphic variants, which may have no or small functional
relevance [49]. This condition is different from the case of a single
pathogenic mtDNA mutation arising on a clonal mitochondrial
genome, which is typical of humans with mitochondrial disorders.
Important differences between the two situations may include the
nucleoid composition and the level of mtDNA exchange, if any,
between nucleoids. Nucleoids seem to follow the faithful replica-
tion model, without consistent genome exchange [6,11,13].
Furthermore, it has been demonstrated that mtDNA molecules
may recombine within mitochondria [50–52], a phenomenon that
is not relevant when mtDNA is clonal as in most humans, but that
may become important in the case of different coexisting genomes
with clusters of distinct variants, as in the heteroplasmic animal
models or sometimes in humans with multiple heteroplasmies [17–
21,53]. No studies address how frequently mtDNA recombination
may occur, in which cell type, or during which stage of germ line
segregation. Neither heteroplasmic animal models [17–21,49] nor
the few available pathologic mito-mouse models [10,23,24] have
been fully exploited yet to answer all these questions.
One final question concerns the possible selective pressure on
mtDNA pathogenic mutations. The currently available mito-mice
clearly indicated that severe mtDNA mutations undergo purifying
selection over a few generations [23,24]. The segregation of the
MELAS mutation in human tissues has been proposed to be non-
random [54], and in vitro studies using cybrids with different
nuclear backgrounds showed that segregation of the mutant
mtDNA could be driven in opposite directions depending on the
nuclear genome [55–57]. Thus, selection of mutant mtDNA may
occur differently in different somatic tissues, impinging on the
phenotypic expression. Whether such a genotypic selection may
also operate during the germ line segregation for ‘‘mild’’ changes,
including the MELAS mutation, is currently debated, casting
doubts on the random genetic drift mechanism [47]. Staining the
ovarian tissue for the histoenzymatic COX/SDH activities failed
Figure 5. Graphical representation of mother-to-offspring transmission of the MELAS mutation in the two Italian families and the
seven other pedigrees retrieved from literature (see Table 1). The mutant load of MELAS mutation (%) is on the y axis. In all panels, the
leftmost point is the mother’s mutant load, connected to each of the offspring mutant load. The reference, the tissues from which mtDNA mutant
load has been assessed and the bottleneck size are indicated.
doi:10.1371/journal.pone.0096663.g005
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to reveal any COX-deficient oocyte, nor other cell types. This may
indicate that in this particular case there was no oocyte with supra-
threshold loads of MELAS mutation or that a very efficient
complementation occurs within oocytes, which may escape in the
case of MELAS mutation any selection along the germline.
In conclusion, the mechanisms governing the germline segre-
gation and the subsequent somatic distribution of single patho-
genic mtDNA mutations in humans remain far from being
elucidated. Our study of mother-to-oocytes/offspring tissues
transmission of the same pathogenic MELAS mutation shows
how wide may be the range of mutant loads segregating through
the same bottleneck size.
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